L. Felt

Comparison of methods employing gas chromatography retention data to determine vapour pressures at 298 K.

L. Streinz, J. Cvačka, V. Svoboda, 2001, Journal of chromatography. A.

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

Reed Johnson, C. Singer, Reed Johnson, 2018, CNS Drugs.

Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3)

W. Oertel, C. Tanner, R. Pahwa, 2017, Movement disorders : official journal of the Movement Disorder Society.

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study

W. Oertel, C. Tanner, R. Pahwa, 2017, Journal of Parkinson's disease.